Novel motif:158
From FANTOM5_SSTAR
name: | motif158_SRCGWYACA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0007586 | digestion | 1.430736e-20 |
GO:0022600 | digestive system process | 9.007673e-16 |
GO:0030277 | maintenance of gastrointestinal epithelium | 1.038167e-15 |
GO:0006955 | immune response | 3.801250e-14 |
GO:0002682 | regulation of immune system process | 1.099963e-13 |
GO:0002684 | positive regulation of immune system process | 1.770712e-13 |
GO:0050776 | regulation of immune response | 7.572308e-13 |
GO:0007166 | cell surface receptor linked signaling pathway | 2.799210e-12 |
GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 3.481990e-12 |
GO:0045576 | mast cell activation | 1.526097e-11 |
GO:0071732 | cellular response to nitric oxide | 1.536546e-11 |
GO:0002376 | immune system process | 1.952498e-11 |
GO:0048537 | mucosal-associated lymphoid tissue development | 3.408947e-11 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 4.115865e-11 |
GO:0048011 | nerve growth factor receptor signaling pathway | 1.552378e-10 |
GO:0050747 | positive regulation of lipoprotein metabolic process | 2.607847e-10 |
GO:0071731 | response to nitric oxide | 3.065184e-10 |
GO:0010669 | epithelial structure maintenance | 3.344695e-10 |
GO:0035094 | response to nicotine | 3.941542e-10 |
GO:0007167 | enzyme linked receptor protein signaling pathway | 4.865647e-10 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 9.645349e-10 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 1.074568e-9 |
GO:0002699 | positive regulation of immune effector process | 1.320076e-9 |
GO:0007616 | long-term memory | 2.065069e-9 |
GO:0050778 | positive regulation of immune response | 2.138945e-9 |
GO:0002385 | mucosal immune response | 2.178114e-9 |
GO:0032656 | regulation of interleukin-13 production | 2.778898e-9 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 4.929665e-9 |
GO:0042167 | heme catabolic process | 7.160204e-9 |
GO:0001821 | histamine secretion | 7.399944e-9 |
GO:0033559 | unsaturated fatty acid metabolic process | 1.070511e-8 |
GO:0031017 | exocrine pancreas development | 1.510558e-8 |
GO:0002443 | leukocyte mediated immunity | 1.552423e-8 |
GO:0051608 | histamine transport | 2.193742e-8 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 2.469149e-8 |
GO:0048541 | Peyer's patch development | 3.231518e-8 |
GO:0046683 | response to organophosphorus | 3.323006e-8 |
GO:0006690 | icosanoid metabolic process | 3.994164e-8 |
GO:0043303 | mast cell degranulation | 5.985762e-8 |
GO:0002426 | immunoglobulin production in mucosal tissue | 7.117268e-8 |
GO:0007165 | signal transduction | 7.283308e-8 |
GO:0070875 | positive regulation of glycogen metabolic process | 9.081109e-8 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 1.037888e-7 |
GO:0002757 | immune response-activating signal transduction | 1.090920e-7 |
GO:0006790 | sulfur compound metabolic process | 1.098708e-7 |
GO:0060789 | hair follicle placode formation | 1.176443e-7 |
GO:0051923 | sulfation | 1.186140e-7 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 1.338732e-7 |
GO:0031347 | regulation of defense response | 1.423220e-7 |
GO:0010906 | regulation of glucose metabolic process | 1.792321e-7 |
GO:0045112 | integrin biosynthetic process | 2.364691e-7 |
GO:0002253 | activation of immune response | 2.389926e-7 |
GO:0045668 | negative regulation of osteoblast differentiation | 2.495636e-7 |
GO:0002764 | immune response-regulating signaling pathway | 2.754998e-7 |
GO:0023052 | signaling | 2.877756e-7 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 2.913360e-7 |
GO:0031915 | positive regulation of synaptic plasticity | 2.952808e-7 |
GO:0010868 | negative regulation of triglyceride biosynthetic process | 3.798122e-7 |
GO:0042104 | positive regulation of activated T cell proliferation | 3.856622e-7 |
GO:0048584 | positive regulation of response to stimulus | 4.066627e-7 |
GO:0042310 | vasoconstriction | 4.218348e-7 |
GO:0047497 | mitochondrion transport along microtubule | 4.573046e-7 |
GO:0032736 | positive regulation of interleukin-13 production | 6.177620e-7 |
GO:0007623 | circadian rhythm | 6.528334e-7 |
GO:0006290 | pyrimidine dimer repair | 7.016871e-7 |
GO:0002697 | regulation of immune effector process | 7.798067e-7 |
GO:0017085 | response to insecticide | 8.906757e-7 |
GO:0017187 | peptidyl-glutamic acid carboxylation | 9.515679e-7 |
GO:0043305 | negative regulation of mast cell degranulation | 1.034364e-6 |
GO:0002274 | myeloid leukocyte activation | 1.054067e-6 |
GO:0050896 | response to stimulus | 1.077838e-6 |
GO:0043392 | negative regulation of DNA binding | 1.096378e-6 |
GO:0032916 | positive regulation of transforming growth factor beta3 production | 1.141906e-6 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 1.242377e-6 |
GO:0060024 | rhythmic synaptic transmission | 1.423084e-6 |
GO:0051915 | induction of synaptic plasticity by chemical substance | 1.473000e-6 |
GO:0002448 | mast cell mediated immunity | 1.543707e-6 |
GO:0010907 | positive regulation of glucose metabolic process | 1.573643e-6 |
GO:0002252 | immune effector process | 1.579001e-6 |
GO:0050892 | intestinal absorption | 1.613208e-6 |
GO:0032103 | positive regulation of response to external stimulus | 1.627859e-6 |
GO:0005979 | regulation of glycogen biosynthetic process | 1.701726e-6 |
GO:0051654 | establishment of mitochondrion localization | 1.839617e-6 |
GO:0043255 | regulation of carbohydrate biosynthetic process | 1.906402e-6 |
GO:0030225 | macrophage differentiation | 2.311545e-6 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 2.407634e-6 |
GO:0045588 | positive regulation of gamma-delta T cell differentiation | 2.432468e-6 |
GO:0007154 | cell communication | 2.559889e-6 |
GO:0002251 | organ or tissue specific immune response | 2.683674e-6 |
GO:0006788 | heme oxidation | 2.718675e-6 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 2.861745e-6 |
GO:0008286 | insulin receptor signaling pathway | 2.915985e-6 |
GO:0045900 | negative regulation of translational elongation | 2.943769e-6 |
GO:0002444 | myeloid leukocyte mediated immunity | 3.124133e-6 |
GO:0046889 | positive regulation of lipid biosynthetic process | 3.169729e-6 |
GO:0051656 | establishment of organelle localization | 3.276209e-6 |
GO:0001779 | natural killer cell differentiation | 3.300935e-6 |
GO:0030719 | P granule organization | 3.463480e-6 |
GO:0002694 | regulation of leukocyte activation | 3.516840e-6 |
GO:0033235 | positive regulation of protein sumoylation | 3.659355e-6 |
GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity | 3.774311e-6 |
GO:0051187 | cofactor catabolic process | 4.597489e-6 |
GO:0045368 | positive regulation of interleukin-13 biosynthetic process | 4.696567e-6 |
GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair | 4.696567e-6 |
GO:0007186 | G-protein coupled receptor protein signaling pathway | 4.756888e-6 |
GO:0001894 | tissue homeostasis | 4.892295e-6 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 4.909030e-6 |
GO:0046544 | development of secondary male sexual characteristics | 5.137743e-6 |
GO:0048583 | regulation of response to stimulus | 5.163923e-6 |
GO:0060290 | transdifferentiation | 5.178618e-6 |
GO:0090207 | regulation of triglyceride metabolic process | 5.357590e-6 |
GO:0042508 | tyrosine phosphorylation of Stat1 protein | 5.392619e-6 |
GO:0042402 | cellular biogenic amine catabolic process | 5.507016e-6 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 5.525566e-6 |
GO:0010675 | regulation of cellular carbohydrate metabolic process | 5.652830e-6 |
GO:0032673 | regulation of interleukin-4 production | 5.656983e-6 |
GO:0006476 | protein deacetylation | 5.765215e-6 |
GO:0007606 | sensory perception of chemical stimulus | 5.820276e-6 |
GO:0032971 | regulation of muscle filament sliding | 6.270818e-6 |
GO:0031103 | axon regeneration | 6.307168e-6 |
GO:0061031 | endodermal digestive tract morphogenesis | 6.637943e-6 |
GO:0032352 | positive regulation of hormone metabolic process | 6.913678e-6 |
GO:0032910 | regulation of transforming growth factor beta3 production | 6.972710e-6 |
GO:0051716 | cellular response to stimulus | 7.222578e-6 |
GO:0006349 | regulation of gene expression by genetic imprinting | 7.515684e-6 |
GO:0006109 | regulation of carbohydrate metabolic process | 7.585935e-6 |
GO:0072333 | signal transduction by p53 class mediator resulting in induction of anoikis | 7.892284e-6 |
GO:0010676 | positive regulation of cellular carbohydrate metabolic process | 8.323506e-6 |
GO:0070741 | response to interleukin-6 | 9.278125e-6 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 9.308550e-6 |
GO:0032689 | negative regulation of interferon-gamma production | 9.767938e-6 |
GO:0008217 | regulation of blood pressure | 1.000287e-5 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 1.012549e-5 |
GO:0032425 | positive regulation of mismatch repair | 1.058323e-5 |
GO:0032781 | positive regulation of ATPase activity | 1.068367e-5 |
GO:0045760 | positive regulation of action potential | 1.096898e-5 |
GO:0070873 | regulation of glycogen metabolic process | 1.097362e-5 |
GO:0035601 | protein deacylation | 1.137513e-5 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 1.183591e-5 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 1.287817e-5 |
GO:0018298 | protein-chromophore linkage | 1.345985e-5 |
GO:0046006 | regulation of activated T cell proliferation | 1.401119e-5 |
GO:0090209 | negative regulation of triglyceride metabolic process | 1.425625e-5 |
GO:0050851 | antigen receptor-mediated signaling pathway | 1.429544e-5 |
GO:0045834 | positive regulation of lipid metabolic process | 1.439551e-5 |
GO:0043179 | rhythmic excitation | 1.502743e-5 |
GO:0031349 | positive regulation of defense response | 1.504370e-5 |
GO:0050870 | positive regulation of T cell activation | 1.511179e-5 |
GO:0002696 | positive regulation of leukocyte activation | 1.641067e-5 |
GO:0042752 | regulation of circadian rhythm | 1.719677e-5 |
GO:0046208 | spermine catabolic process | 1.732056e-5 |
GO:0051958 | methotrexate transport | 1.740966e-5 |
GO:0046645 | positive regulation of gamma-delta T cell activation | 1.916648e-5 |
GO:0048675 | axon extension | 2.205065e-5 |
GO:0040018 | positive regulation of multicellular organism growth | 2.296089e-5 |
GO:0007263 | nitric oxide mediated signal transduction | 2.297626e-5 |
GO:0002708 | positive regulation of lymphocyte mediated immunity | 2.299587e-5 |
GO:0051249 | regulation of lymphocyte activation | 2.326462e-5 |
GO:0050865 | regulation of cell activation | 2.371596e-5 |
GO:0034378 | chylomicron assembly | 2.377606e-5 |
GO:0035967 | cellular response to topologically incorrect protein | 2.395505e-5 |
GO:0060155 | platelet dense granule organization | 2.426579e-5 |
GO:0006066 | alcohol metabolic process | 2.601161e-5 |
GO:0006691 | leukotriene metabolic process | 2.604969e-5 |
GO:0002553 | histamine secretion by mast cell | 2.670484e-5 |
GO:0050867 | positive regulation of cell activation | 2.678215e-5 |
GO:0070849 | response to epidermal growth factor stimulus | 2.698689e-5 |
GO:0031959 | mineralocorticoid receptor signaling pathway | 2.746458e-5 |
GO:0010893 | positive regulation of steroid biosynthetic process | 2.815486e-5 |
GO:0015817 | histidine transport | 2.958315e-5 |
GO:0035166 | post-embryonic hemopoiesis | 3.052116e-5 |
GO:0050727 | regulation of inflammatory response | 3.283751e-5 |
GO:0046886 | positive regulation of hormone biosynthetic process | 3.316819e-5 |
GO:0061162 | establishment of monopolar cell polarity | 3.334364e-5 |
GO:0045630 | positive regulation of T-helper 2 cell differentiation | 3.357399e-5 |
GO:0046456 | icosanoid biosynthetic process | 3.408650e-5 |
GO:0006952 | defense response | 3.433373e-5 |
GO:0048711 | positive regulation of astrocyte differentiation | 3.745440e-5 |
GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway | 3.806789e-5 |
GO:0033194 | response to hydroperoxide | 3.860965e-5 |
GO:0042420 | dopamine catabolic process | 3.921851e-5 |
GO:0045940 | positive regulation of steroid metabolic process | 3.959605e-5 |
GO:0051251 | positive regulation of lymphocyte activation | 4.059454e-5 |
GO:0010866 | regulation of triglyceride biosynthetic process | 4.162546e-5 |
GO:0050729 | positive regulation of inflammatory response | 4.406757e-5 |
GO:0008215 | spermine metabolic process | 4.445265e-5 |
GO:0045471 | response to ethanol | 4.583251e-5 |
GO:0007567 | parturition | 4.738016e-5 |
GO:0048872 | homeostasis of number of cells | 4.915966e-5 |
GO:0007259 | JAK-STAT cascade | 5.060623e-5 |
GO:0032946 | positive regulation of mononuclear cell proliferation | 5.130131e-5 |
GO:0048710 | regulation of astrocyte differentiation | 5.219429e-5 |
GO:0006897 | endocytosis | 5.273954e-5 |
GO:0070306 | lens fiber cell differentiation | 5.341142e-5 |
GO:0007569 | cell aging | 5.551009e-5 |
GO:0060249 | anatomical structure homeostasis | 6.000420e-5 |
GO:2000273 | positive regulation of receptor activity | 6.128950e-5 |
GO:0043304 | regulation of mast cell degranulation | 6.224076e-5 |
GO:0048676 | axon extension involved in development | 6.343367e-5 |
GO:0006103 | 2-oxoglutarate metabolic process | 6.468575e-5 |
GO:0045088 | regulation of innate immune response | 6.541101e-5 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 6.558373e-5 |
GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development | 6.588742e-5 |
GO:0016311 | dephosphorylation | 6.670690e-5 |
GO:0070665 | positive regulation of leukocyte proliferation | 6.694259e-5 |
GO:0050863 | regulation of T cell activation | 6.954851e-5 |
GO:0033363 | secretory granule organization | 7.097819e-5 |
GO:0043206 | fibril organization | 7.156037e-5 |
GO:0080134 | regulation of response to stress | 7.209443e-5 |
GO:0050771 | negative regulation of axonogenesis | 7.220957e-5 |
GO:0010565 | regulation of cellular ketone metabolic process | 7.241239e-5 |
GO:0045721 | negative regulation of gluconeogenesis | 7.415712e-5 |
GO:0019370 | leukotriene biosynthetic process | 7.515562e-5 |
GO:0007187 | G-protein signaling, coupled to cyclic nucleotide second messenger | 7.760791e-5 |
GO:0046173 | polyol biosynthetic process | 8.043352e-5 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 8.309590e-5 |
GO:0042692 | muscle cell differentiation | 8.387443e-5 |
GO:2000210 | positive regulation of anoikis | 8.407612e-5 |
GO:0042424 | catecholamine catabolic process | 8.414492e-5 |
GO:0042045 | epithelial fluid transport | 8.437553e-5 |
GO:0010469 | regulation of receptor activity | 8.461838e-5 |
GO:0042269 | regulation of natural killer cell mediated cytotoxicity | 9.232078e-5 |
GO:0044241 | lipid digestion | 9.302379e-5 |
GO:0043279 | response to alkaloid | 9.339465e-5 |
GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 9.341022e-5 |
GO:0060916 | mesenchymal cell proliferation involved in lung development | 9.341022e-5 |
GO:0050671 | positive regulation of lymphocyte proliferation | 9.356094e-5 |
GO:0045321 | leukocyte activation | 9.957656e-5 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.022951e-4 |
GO:0065008 | regulation of biological quality | 1.056966e-4 |
GO:0043300 | regulation of leukocyte degranulation | 1.169714e-4 |
GO:0050663 | cytokine secretion | 1.182726e-4 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 1.182726e-4 |
GO:0032864 | activation of Cdc42 GTPase activity | 1.185806e-4 |
GO:0051004 | regulation of lipoprotein lipase activity | 1.202377e-4 |
GO:0042592 | homeostatic process | 1.215361e-4 |
GO:0019216 | regulation of lipid metabolic process | 1.261664e-4 |
GO:0070307 | lens fiber cell development | 1.295764e-4 |
GO:0045792 | negative regulation of cell size | 1.385788e-4 |
GO:0035634 | response to stilbenoid | 1.394327e-4 |
GO:0071318 | cellular response to ATP | 1.408597e-4 |
GO:0070887 | cellular response to chemical stimulus | 1.409925e-4 |
GO:0003166 | bundle of His development | 1.426680e-4 |
GO:0061024 | membrane organization | 1.440604e-4 |
GO:0031295 | T cell costimulation | 1.461647e-4 |
GO:0006982 | response to lipid hydroperoxide | 1.467460e-4 |
GO:0014829 | vascular smooth muscle contraction | 1.476321e-4 |
GO:0006470 | protein dephosphorylation | 1.586916e-4 |
GO:0030099 | myeloid cell differentiation | 1.612146e-4 |
GO:0006693 | prostaglandin metabolic process | 1.621872e-4 |
GO:0000088 | mitotic prophase | 1.661731e-4 |
GO:0014012 | peripheral nervous system axon regeneration | 1.733330e-4 |
GO:0072678 | T cell migration | 1.758890e-4 |
GO:0014806 | smooth muscle hyperplasia | 1.772474e-4 |
GO:0031667 | response to nutrient levels | 1.812337e-4 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 1.854430e-4 |
GO:0018293 | protein-FAD linkage | 1.854430e-4 |
GO:0002005 | angiotensin catabolic process in blood | 1.854430e-4 |
GO:0050852 | T cell receptor signaling pathway | 1.861061e-4 |
GO:0050768 | negative regulation of neurogenesis | 1.868943e-4 |
GO:0007635 | chemosensory behavior | 1.886743e-4 |
GO:0003014 | renal system process | 1.894766e-4 |
GO:0048247 | lymphocyte chemotaxis | 1.908136e-4 |
GO:0033189 | response to vitamin A | 1.925517e-4 |
GO:0016044 | cellular membrane organization | 1.936038e-4 |
GO:0033273 | response to vitamin | 1.963824e-4 |
GO:0002720 | positive regulation of cytokine production involved in immune response | 1.966980e-4 |
GO:0035418 | protein localization to synapse | 2.011437e-4 |
GO:0035712 | T-helper 2 cell activation | 2.022432e-4 |
GO:2000525 | positive regulation of T cell costimulation | 2.022432e-4 |
GO:0071954 | chemokine (C-C motif) ligand 11 production | 2.022432e-4 |
GO:0002215 | defense response to nematode | 2.022432e-4 |
GO:0035708 | interleukin-4-dependent isotype switching to IgE isotypes | 2.022432e-4 |
GO:0035709 | memory T cell activation | 2.022432e-4 |
GO:0010830 | regulation of myotube differentiation | 2.047675e-4 |
GO:0060341 | regulation of cellular localization | 2.063782e-4 |
GO:0033007 | negative regulation of mast cell activation involved in immune response | 2.072015e-4 |
GO:0051016 | barbed-end actin filament capping | 2.088217e-4 |
GO:0001986 | negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure | 2.122582e-4 |
GO:0034101 | erythrocyte homeostasis | 2.167075e-4 |
GO:0002449 | lymphocyte mediated immunity | 2.170707e-4 |
GO:0050746 | regulation of lipoprotein metabolic process | 2.259395e-4 |
GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis | 2.278033e-4 |
GO:2000791 | negative regulation of mesenchymal cell proliferation involved in lung development | 2.278033e-4 |
GO:0021740 | principal sensory nucleus of trigeminal nerve development | 2.278033e-4 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 2.278033e-4 |
GO:0061141 | lung ciliated cell differentiation | 2.278033e-4 |
GO:0045840 | positive regulation of mitosis | 2.324330e-4 |
GO:0007613 | memory | 2.354798e-4 |
GO:0032350 | regulation of hormone metabolic process | 2.362708e-4 |
GO:0033160 | positive regulation of protein import into nucleus, translocation | 2.449284e-4 |
GO:0002237 | response to molecule of bacterial origin | 2.477623e-4 |
GO:0007588 | excretion | 2.521204e-4 |
GO:0001798 | positive regulation of type IIa hypersensitivity | 2.536263e-4 |
GO:0043301 | negative regulation of leukocyte degranulation | 2.595979e-4 |
GO:0035264 | multicellular organism growth | 2.616629e-4 |
GO:0033006 | regulation of mast cell activation involved in immune response | 2.617761e-4 |
GO:0009650 | UV protection | 2.653676e-4 |
GO:0050690 | regulation of defense response to virus by virus | 2.673346e-4 |
GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 2.689850e-4 |
GO:0051101 | regulation of DNA binding | 2.710697e-4 |
GO:0090030 | regulation of steroid hormone biosynthetic process | 2.785545e-4 |
GO:0048678 | response to axon injury | 2.840639e-4 |
GO:0002002 | regulation of angiotensin levels in blood | 2.850176e-4 |
GO:0060684 | epithelial-mesenchymal cell signaling | 2.852841e-4 |
GO:0006107 | oxaloacetate metabolic process | 2.863542e-4 |
GO:0045445 | myoblast differentiation | 2.964772e-4 |
GO:0030185 | nitric oxide transport | 3.002825e-4 |
GO:0051764 | actin crosslink formation | 3.009161e-4 |
GO:0070141 | response to UV-A | 3.113053e-4 |
GO:0015833 | peptide transport | 3.143554e-4 |
GO:0045089 | positive regulation of innate immune response | 3.206267e-4 |
GO:0046500 | S-adenosylmethionine metabolic process | 3.223052e-4 |
GO:0030449 | regulation of complement activation | 3.259010e-4 |
GO:0060502 | epithelial cell proliferation involved in lung morphogenesis | 3.267129e-4 |
GO:0070309 | lens fiber cell morphogenesis | 3.267129e-4 |
GO:0032663 | regulation of interleukin-2 production | 3.295959e-4 |
GO:0002702 | positive regulation of production of molecular mediator of immune response | 3.349195e-4 |
GO:0001817 | regulation of cytokine production | 3.361718e-4 |
GO:0035083 | cilium axoneme assembly | 3.367464e-4 |
GO:0046888 | negative regulation of hormone secretion | 3.373779e-4 |
GO:0048691 | positive regulation of axon extension involved in regeneration | 3.451561e-4 |
GO:0019056 | modulation by virus of host transcription | 3.451561e-4 |
GO:0060414 | aorta smooth muscle tissue morphogenesis | 3.468237e-4 |
GO:0090398 | cellular senescence | 3.478987e-4 |
GO:0003008 | system process | 3.568215e-4 |
GO:0030388 | fructose 1,6-bisphosphate metabolic process | 3.576935e-4 |
GO:0006909 | phagocytosis | 3.605243e-4 |
GO:0002275 | myeloid cell activation involved in immune response | 3.613810e-4 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 3.641962e-4 |
GO:0042313 | protein kinase C deactivation | 3.790343e-4 |
GO:0031583 | activation of phospholipase D activity by G-protein coupled receptor protein signaling pathway | 3.790343e-4 |
GO:0032496 | response to lipopolysaccharide | 3.880234e-4 |
GO:0032753 | positive regulation of interleukin-4 production | 3.902934e-4 |
GO:0015866 | ADP transport | 3.931153e-4 |
GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | 3.964118e-4 |
GO:0009617 | response to bacterium | 3.990321e-4 |
GO:0072593 | reactive oxygen species metabolic process | 4.073814e-4 |
GO:0060426 | lung vasculature development | 4.271005e-4 |
GO:0048625 | myoblast cell fate commitment | 4.393932e-4 |
GO:0034976 | response to endoplasmic reticulum stress | 4.438536e-4 |
GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response | 4.533233e-4 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 4.582216e-4 |
GO:0051146 | striated muscle cell differentiation | 4.585707e-4 |
GO:0031343 | positive regulation of cell killing | 4.591045e-4 |
GO:0072307 | regulation of metanephric nephron tubule epithelial cell differentiation | 4.604826e-4 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 4.606031e-4 |
GO:0048690 | regulation of axon extension involved in regeneration | 4.633037e-4 |
GO:0003093 | regulation of glomerular filtration | 4.674265e-4 |
GO:0016049 | cell growth | 4.711456e-4 |
GO:0006984 | ER-nucleus signaling pathway | 4.724766e-4 |
GO:0060158 | activation of phospholipase C activity by dopamine receptor signaling pathway | 4.751061e-4 |
GO:0006021 | inositol biosynthetic process | 4.753637e-4 |
GO:0001775 | cell activation | 4.767750e-4 |
GO:0072201 | negative regulation of mesenchymal cell proliferation | 4.807769e-4 |
GO:0043029 | T cell homeostasis | 4.971290e-4 |
GO:0002920 | regulation of humoral immune response | 5.121936e-4 |
GO:0050878 | regulation of body fluid levels | 5.171970e-4 |
GO:0006029 | proteoglycan metabolic process | 5.200352e-4 |
GO:0033233 | regulation of protein sumoylation | 5.206531e-4 |
GO:0030204 | chondroitin sulfate metabolic process | 5.272374e-4 |
GO:0001970 | positive regulation of activation of membrane attack complex | 5.300877e-4 |
GO:0070293 | renal absorption | 5.341653e-4 |
GO:0007016 | cytoskeletal anchoring at plasma membrane | 5.427965e-4 |
GO:0016925 | protein sumoylation | 5.432524e-4 |
GO:0051640 | organelle localization | 5.490475e-4 |
GO:0001819 | positive regulation of cytokine production | 5.495408e-4 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 5.509483e-4 |
GO:0072676 | lymphocyte migration | 5.912718e-4 |
GO:0002019 | regulation of renal output by angiotensin | 5.929149e-4 |
GO:0030201 | heparan sulfate proteoglycan metabolic process | 5.944177e-4 |
GO:0007260 | tyrosine phosphorylation of STAT protein | 5.980238e-4 |
GO:0016575 | histone deacetylation | 6.020798e-4 |
GO:0046883 | regulation of hormone secretion | 6.198109e-4 |
GO:0021884 | forebrain neuron development | 6.222036e-4 |
GO:0030097 | hemopoiesis | 6.225304e-4 |
GO:0007611 | learning or memory | 6.280293e-4 |
GO:0046849 | bone remodeling | 6.339659e-4 |
GO:0000072 | M phase specific microtubule process | 6.501052e-4 |
GO:0048199 | vesicle targeting, to, from or within Golgi | 6.626110e-4 |
GO:0009605 | response to external stimulus | 6.801246e-4 |
GO:0042137 | sequestering of neurotransmitter | 6.850012e-4 |
GO:0040023 | establishment of nucleus localization | 6.917897e-4 |
GO:0045047 | protein targeting to ER | 6.984668e-4 |
GO:0046890 | regulation of lipid biosynthetic process | 7.091142e-4 |
GO:0007608 | sensory perception of smell | 7.152017e-4 |
GO:0071514 | genetic imprinting | 7.164854e-4 |
GO:0045923 | positive regulation of fatty acid metabolic process | 7.255088e-4 |
GO:0051647 | nucleus localization | 7.317177e-4 |
GO:0019935 | cyclic-nucleotide-mediated signaling | 7.430023e-4 |
GO:0032869 | cellular response to insulin stimulus | 7.527937e-4 |
GO:0001912 | positive regulation of leukocyte mediated cytotoxicity | 7.629264e-4 |
GO:0060742 | epithelial cell differentiation involved in prostate gland development | 7.641131e-4 |
GO:0018200 | peptidyl-glutamic acid modification | 7.670447e-4 |
GO:0046626 | regulation of insulin receptor signaling pathway | 7.748758e-4 |
GO:0001909 | leukocyte mediated cytotoxicity | 7.755843e-4 |
GO:0001757 | somite specification | 7.874990e-4 |
GO:0007610 | behavior | 7.972540e-4 |
GO:0032633 | interleukin-4 production | 8.001765e-4 |
GO:0001865 | NK T cell differentiation | 8.001765e-4 |
GO:0006821 | chloride transport | 8.159974e-4 |
GO:0045777 | positive regulation of blood pressure | 8.208021e-4 |
GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion | 8.384912e-4 |
GO:0043248 | proteasome assembly | 8.429374e-4 |
GO:0006101 | citrate metabolic process | 8.429374e-4 |
GO:0060612 | adipose tissue development | 8.494915e-4 |
GO:0046813 | virion attachment, binding of host cell surface receptor | 8.590803e-4 |
GO:0045199 | maintenance of epithelial cell apical/basal polarity | 8.611803e-4 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 8.611803e-4 |
GO:0009991 | response to extracellular stimulus | 8.896296e-4 |
GO:0072044 | collecting duct development | 8.944955e-4 |
GO:0048588 | developmental cell growth | 8.995006e-4 |
GO:0008063 | Toll signaling pathway | 9.002068e-4 |
GO:0044240 | multicellular organismal lipid catabolic process | 9.019588e-4 |
GO:0048016 | inositol phosphate-mediated signaling | 9.413256e-4 |
GO:0046655 | folic acid metabolic process | 9.483967e-4 |
GO:0033003 | regulation of mast cell activation | 9.507279e-4 |
GO:0002885 | positive regulation of hypersensitivity | 9.591889e-4 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 9.640806e-4 |
GO:0035556 | intracellular signal transduction | 9.644992e-4 |
GO:0006575 | cellular modified amino acid metabolic process | 9.724320e-4 |
GO:0002790 | peptide secretion | 9.816290e-4 |
GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 9.861628e-4 |
GO:0048265 | response to pain | 1.010443e-3 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 1.016472e-3 |
GO:0072376 | protein activation cascade | 1.020477e-3 |
GO:0060137 | maternal process involved in parturition | 1.039409e-3 |
GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.040206e-3 |
GO:0006598 | polyamine catabolic process | 1.041178e-3 |
GO:0035269 | protein O-linked mannosylation | 1.075906e-3 |
GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly | 1.075906e-3 |
GO:0001906 | cell killing | 1.076082e-3 |
GO:0019062 | virion attachment to host cell surface receptor | 1.085834e-3 |
GO:0002520 | immune system development | 1.086912e-3 |
GO:0032929 | negative regulation of superoxide anion generation | 1.089402e-3 |
GO:0071715 | icosanoid transport | 1.097993e-3 |
GO:0031345 | negative regulation of cell projection organization | 1.104025e-3 |
GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process | 1.114668e-3 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 1.121224e-3 |
GO:0031175 | neuron projection development | 1.121964e-3 |
GO:0045685 | regulation of glial cell differentiation | 1.131533e-3 |
GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 1.138459e-3 |
GO:0019932 | second-messenger-mediated signaling | 1.146705e-3 |
GO:0042136 | neurotransmitter biosynthetic process | 1.146953e-3 |
GO:0035413 | positive regulation of catenin import into nucleus | 1.146953e-3 |
GO:0006692 | prostanoid metabolic process | 1.147102e-3 |
GO:0071375 | cellular response to peptide hormone stimulus | 1.152967e-3 |
GO:0090026 | positive regulation of monocyte chemotaxis | 1.184759e-3 |
GO:0045600 | positive regulation of fat cell differentiation | 1.185917e-3 |
GO:0042221 | response to chemical stimulus | 1.193458e-3 |
GO:0006885 | regulation of pH | 1.195852e-3 |
GO:0007155 | cell adhesion | 1.204691e-3 |
GO:0016192 | vesicle-mediated transport | 1.208126e-3 |
GO:0035278 | negative regulation of translation involved in gene silencing by miRNA | 1.208538e-3 |
GO:0006106 | fumarate metabolic process | 1.209615e-3 |
GO:0015844 | monoamine transport | 1.223597e-3 |
GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation | 1.228808e-3 |
GO:0009914 | hormone transport | 1.253192e-3 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 1.261086e-3 |
GO:0042102 | positive regulation of T cell proliferation | 1.265018e-3 |
GO:0050862 | positive regulation of T cell receptor signaling pathway | 1.301369e-3 |
GO:0060297 | regulation of sarcomere organization | 1.320106e-3 |
GO:0045082 | positive regulation of interleukin-10 biosynthetic process | 1.326615e-3 |
GO:0060306 | regulation of membrane repolarization | 1.338191e-3 |
GO:0007015 | actin filament organization | 1.347705e-3 |
GO:0051017 | actin filament bundle assembly | 1.378789e-3 |
GO:2000612 | regulation of thyroid-stimulating hormone secretion | 1.380309e-3 |
GO:0032637 | interleukin-8 production | 1.409130e-3 |
GO:0001886 | endothelial cell morphogenesis | 1.411557e-3 |
GO:0071679 | commissural neuron axon guidance | 1.411557e-3 |
GO:0010898 | positive regulation of triglyceride catabolic process | 1.420324e-3 |
GO:0010954 | positive regulation of protein processing | 1.423265e-3 |
GO:0045739 | positive regulation of DNA repair | 1.431844e-3 |
GO:0048871 | multicellular organismal homeostasis | 1.438538e-3 |
GO:0030538 | embryonic genitalia morphogenesis | 1.439105e-3 |
GO:0006007 | glucose catabolic process | 1.450606e-3 |
GO:0015837 | amine transport | 1.456339e-3 |
GO:0045622 | regulation of T-helper cell differentiation | 1.483978e-3 |
GO:0006954 | inflammatory response | 1.484645e-3 |
GO:0055123 | digestive system development | 1.486263e-3 |
GO:0002089 | lens morphogenesis in camera-type eye | 1.490072e-3 |
GO:0071705 | nitrogen compound transport | 1.518777e-3 |
GO:0090136 | epithelial cell-cell adhesion | 1.533805e-3 |
GO:0048857 | neural nucleus development | 1.548327e-3 |
GO:0060399 | positive regulation of growth hormone receptor signaling pathway | 1.556406e-3 |
GO:0070295 | renal water absorption | 1.578293e-3 |
GO:0008015 | blood circulation | 1.582536e-3 |
GO:0002088 | lens development in camera-type eye | 1.591264e-3 |
GO:0090322 | regulation of superoxide metabolic process | 1.598632e-3 |
GO:0006471 | protein ADP-ribosylation | 1.599885e-3 |
GO:0040007 | growth | 1.605440e-3 |
GO:0032862 | activation of Rho GTPase activity | 1.612265e-3 |
GO:0032674 | regulation of interleukin-5 production | 1.614756e-3 |
GO:0035409 | histone H3-Y41 phosphorylation | 1.629819e-3 |
GO:0008636 | activation of caspase activity by protein phosphorylation | 1.629819e-3 |
GO:0003073 | regulation of systemic arterial blood pressure | 1.636794e-3 |
GO:0032101 | regulation of response to external stimulus | 1.641498e-3 |
GO:0034134 | toll-like receptor 2 signaling pathway | 1.669318e-3 |
GO:0034130 | toll-like receptor 1 signaling pathway | 1.669318e-3 |
GO:0048384 | retinoic acid receptor signaling pathway | 1.674593e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0042135 | neurotransmitter catabolic process | 5.814742e-17 |
GO:0042133 | neurotransmitter metabolic process | 1.625236e-13 |
GO:0006581 | acetylcholine catabolic process | 3.177491e-13 |
GO:0008291 | acetylcholine metabolic process | 8.280452e-12 |
GO:2000253 | positive regulation of feeding behavior | 9.007072e-10 |
GO:2000507 | positive regulation of energy homeostasis | 9.007072e-10 |
GO:0045212 | neurotransmitter receptor biosynthetic process | 9.945031e-9 |
GO:0030299 | intestinal cholesterol absorption | 5.311963e-8 |
GO:0070252 | actin-mediated cell contraction | 7.108710e-8 |
GO:0071670 | smooth muscle cell chemotaxis | 7.168768e-8 |
GO:0060981 | cell migration involved in coronary angiogenesis | 7.168768e-8 |
GO:0060561 | apoptosis involved in morphogenesis | 8.811427e-8 |
GO:2000505 | regulation of energy homeostasis | 9.865562e-8 |
GO:0045933 | positive regulation of muscle contraction | 9.929495e-8 |
GO:0034767 | positive regulation of ion transmembrane transport | 1.805215e-7 |
GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 1.979370e-7 |
GO:0006200 | ATP catabolic process | 2.321684e-7 |
GO:0010949 | negative regulation of intestinal phytosterol absorption | 3.419474e-7 |
GO:0045796 | negative regulation of intestinal cholesterol absorption | 3.419474e-7 |
GO:0030036 | actin cytoskeleton organization | 4.185390e-7 |
GO:0060978 | angiogenesis involved in coronary vascular morphogenesis | 4.241433e-7 |
GO:0032418 | lysosome localization | 4.241433e-7 |
GO:0033275 | actin-myosin filament sliding | 4.865548e-7 |
GO:0030029 | actin filament-based process | 5.349123e-7 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 7.044409e-7 |
GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 8.647282e-7 |
GO:0019695 | choline metabolic process | 1.547261e-6 |
GO:0090280 | positive regulation of calcium ion import | 1.648992e-6 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 1.648992e-6 |
GO:0003229 | ventricular cardiac muscle tissue development | 1.740589e-6 |
GO:0090361 | regulation of platelet-derived growth factor production | 2.900669e-6 |
GO:0003015 | heart process | 3.555011e-6 |
GO:0001516 | prostaglandin biosynthetic process | 4.253125e-6 |
GO:0071877 | regulation of adrenergic receptor signaling pathway | 4.728047e-6 |
GO:0006540 | glutamate decarboxylation to succinate | 5.056571e-6 |
GO:0072539 | T-helper 17 cell differentiation | 5.056571e-6 |
GO:0030239 | myofibril assembly | 6.449267e-6 |
GO:0010631 | epithelial cell migration | 6.500977e-6 |
GO:0010842 | retina layer formation | 7.380483e-6 |
GO:0035621 | ER to Golgi ceramide transport | 8.351542e-6 |
GO:0030004 | cellular monovalent inorganic cation homeostasis | 9.817493e-6 |
GO:0010623 | developmental programmed cell death | 1.067519e-5 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 1.359152e-5 |
GO:0006308 | DNA catabolic process | 1.364631e-5 |
GO:0060457 | negative regulation of digestive system process | 1.824837e-5 |
GO:0006693 | prostaglandin metabolic process | 1.946695e-5 |
GO:0002027 | regulation of heart rate | 2.078421e-5 |
GO:0045851 | pH reduction | 2.115649e-5 |
GO:0072110 | glomerular mesangial cell proliferation | 2.147509e-5 |
GO:0006289 | nucleotide-excision repair | 2.824694e-5 |
GO:0048738 | cardiac muscle tissue development | 2.877215e-5 |
GO:0030641 | regulation of cellular pH | 2.926686e-5 |
GO:0051561 | elevation of mitochondrial calcium ion concentration | 3.001587e-5 |
GO:0035886 | vascular smooth muscle cell differentiation | 3.037844e-5 |
GO:0055002 | striated muscle cell development | 3.053811e-5 |
GO:0051452 | intracellular pH reduction | 3.123026e-5 |
GO:0060420 | regulation of heart growth | 3.242328e-5 |
GO:0061072 | iris morphogenesis | 3.320398e-5 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 3.705354e-5 |
GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development | 3.777514e-5 |
GO:0071879 | positive regulation of adrenergic receptor signaling pathway | 3.777514e-5 |
GO:0030098 | lymphocyte differentiation | 3.914911e-5 |
GO:0060042 | retina morphogenesis in camera-type eye | 4.016600e-5 |
GO:0031032 | actomyosin structure organization | 4.063207e-5 |
GO:0060427 | lung connective tissue development | 4.309742e-5 |
GO:0046456 | icosanoid biosynthetic process | 4.387459e-5 |
GO:0090076 | relaxation of skeletal muscle | 4.689122e-5 |
GO:0032470 | elevation of endoplasmic reticulum calcium ion concentration | 4.689122e-5 |
GO:0044027 | hypermethylation of CpG island | 4.700736e-5 |
GO:0055021 | regulation of cardiac muscle tissue growth | 4.845127e-5 |
GO:0014819 | regulation of skeletal muscle contraction | 4.853590e-5 |
GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein | 5.178566e-5 |
GO:0008219 | cell death | 5.339843e-5 |
GO:0016338 | calcium-independent cell-cell adhesion | 5.541517e-5 |
GO:0046037 | GMP metabolic process | 5.598020e-5 |
GO:0009056 | catabolic process | 5.653469e-5 |
GO:0007283 | spermatogenesis | 5.972868e-5 |
GO:0016265 | death | 6.122188e-5 |
GO:0060047 | heart contraction | 6.208426e-5 |
GO:0012501 | programmed cell death | 7.634741e-5 |
GO:0043462 | regulation of ATPase activity | 7.727382e-5 |
GO:0048739 | cardiac muscle fiber development | 8.622080e-5 |
GO:0001708 | cell fate specification | 9.088059e-5 |
GO:0042402 | cellular biogenic amine catabolic process | 9.385740e-5 |
GO:0006690 | icosanoid metabolic process | 9.470953e-5 |
GO:0045989 | positive regulation of striated muscle contraction | 9.552985e-5 |
GO:0042093 | T-helper cell differentiation | 9.559265e-5 |
GO:0030048 | actin filament-based movement | 9.750230e-5 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 1.067956e-4 |
GO:0006942 | regulation of striated muscle contraction | 1.076819e-4 |
GO:0046427 | positive regulation of JAK-STAT cascade | 1.108678e-4 |
GO:0055001 | muscle cell development | 1.156216e-4 |
GO:0006915 | apoptosis | 1.188897e-4 |
GO:0055003 | cardiac myofibril assembly | 1.290727e-4 |
GO:0006663 | platelet activating factor biosynthetic process | 1.303238e-4 |
GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 1.360266e-4 |
GO:0006904 | vesicle docking involved in exocytosis | 1.377232e-4 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 1.483700e-4 |
GO:0000302 | response to reactive oxygen species | 1.514129e-4 |
GO:0007522 | visceral muscle development | 1.618756e-4 |
GO:2000573 | positive regulation of DNA biosynthetic process | 1.681345e-4 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 1.681345e-4 |
GO:0090279 | regulation of calcium ion import | 1.698515e-4 |
GO:0030049 | muscle filament sliding | 1.747261e-4 |
GO:0060059 | embryonic retina morphogenesis in camera-type eye | 1.750844e-4 |
GO:0070358 | actin polymerization-dependent cell motility | 1.785157e-4 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 1.785157e-4 |
GO:0006649 | phospholipid transfer to membrane | 1.785157e-4 |
GO:0042938 | dipeptide transport | 1.785157e-4 |
GO:0045987 | positive regulation of smooth muscle contraction | 1.839645e-4 |
GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 1.950062e-4 |
GO:0070165 | positive regulation of adiponectin secretion | 1.986863e-4 |
GO:0070535 | histone H2A K63-linked ubiquitination | 1.986863e-4 |
GO:0033031 | positive regulation of neutrophil apoptosis | 1.986863e-4 |
GO:0006259 | DNA metabolic process | 2.060634e-4 |
GO:0071529 | cementum mineralization | 2.098511e-4 |
GO:0090130 | tissue migration | 2.115585e-4 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 2.134444e-4 |
GO:0035845 | photoreceptor cell outer segment organization | 2.134444e-4 |
GO:0055007 | cardiac muscle cell differentiation | 2.155840e-4 |
GO:0055008 | cardiac muscle tissue morphogenesis | 2.193575e-4 |
GO:0035051 | cardiac cell differentiation | 2.292722e-4 |
GO:0010269 | response to selenium ion | 2.496988e-4 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 2.570370e-4 |
GO:0002021 | response to dietary excess | 2.618710e-4 |
GO:0045213 | neurotransmitter receptor metabolic process | 2.732387e-4 |
GO:0009410 | response to xenobiotic stimulus | 2.850134e-4 |
GO:0072593 | reactive oxygen species metabolic process | 2.887644e-4 |
GO:0003218 | cardiac left ventricle formation | 3.096845e-4 |
GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein | 3.130768e-4 |
GO:0046649 | lymphocyte activation | 3.259974e-4 |
GO:0071866 | negative regulation of apoptosis in bone marrow | 3.270424e-4 |
GO:0055024 | regulation of cardiac muscle tissue development | 3.271443e-4 |
GO:0002293 | alpha-beta T cell differentiation involved in immune response | 3.400409e-4 |
GO:0031448 | positive regulation of fast-twitch skeletal muscle fiber contraction | 3.630177e-4 |
GO:0014909 | smooth muscle cell migration | 3.647169e-4 |
GO:0003278 | apoptosis involved in heart morphogenesis | 3.740410e-4 |
GO:0042743 | hydrogen peroxide metabolic process | 3.912136e-4 |
GO:0042891 | antibiotic transport | 3.956880e-4 |
GO:0046034 | ATP metabolic process | 4.062034e-4 |
GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis | 4.137560e-4 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 4.309427e-4 |
GO:0046686 | response to cadmium ion | 4.329762e-4 |
GO:0001885 | endothelial cell development | 4.496897e-4 |
GO:0044248 | cellular catabolic process | 4.516419e-4 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 4.557440e-4 |
GO:0033197 | response to vitamin E | 4.572357e-4 |
GO:0021861 | forebrain radial glial cell differentiation | 4.572357e-4 |
GO:0060044 | negative regulation of cardiac muscle cell proliferation | 4.693527e-4 |
GO:0051354 | negative regulation of oxidoreductase activity | 4.693527e-4 |
GO:0060969 | negative regulation of gene silencing | 4.736465e-4 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 4.930529e-4 |
GO:0060043 | regulation of cardiac muscle cell proliferation | 5.078008e-4 |
GO:0010614 | negative regulation of cardiac muscle hypertrophy | 5.151159e-4 |
GO:0043248 | proteasome assembly | 5.500329e-4 |
GO:0002287 | alpha-beta T cell activation involved in immune response | 5.626219e-4 |
GO:0032411 | positive regulation of transporter activity | 5.796300e-4 |
GO:0001701 | in utero embryonic development | 5.840320e-4 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 6.111199e-4 |
GO:0072109 | glomerular mesangium development | 6.175980e-4 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 6.175980e-4 |
GO:0033591 | response to L-ascorbic acid | 6.261338e-4 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 6.280488e-4 |
GO:0055006 | cardiac cell development | 6.311111e-4 |
GO:0003166 | bundle of His development | 6.374233e-4 |
GO:0060479 | lung cell differentiation | 6.471964e-4 |
GO:0007340 | acrosome reaction | 6.926861e-4 |
GO:0060710 | chorio-allantoic fusion | 7.167516e-4 |
GO:0010312 | detoxification of zinc ion | 7.168625e-4 |
GO:0045900 | negative regulation of translational elongation | 7.212536e-4 |
GO:0019428 | allantoin biosynthetic process | 7.212536e-4 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 7.212536e-4 |
GO:0018293 | protein-FAD linkage | 7.212536e-4 |
GO:0032720 | negative regulation of tumor necrosis factor production | 7.515228e-4 |
GO:0051494 | negative regulation of cytoskeleton organization | 7.516612e-4 |
GO:0045823 | positive regulation of heart contraction | 7.597683e-4 |
GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 7.724124e-4 |
GO:0010639 | negative regulation of organelle organization | 7.731884e-4 |
GO:0045214 | sarcomere organization | 7.754683e-4 |
GO:0043949 | regulation of cAMP-mediated signaling | 7.786754e-4 |
GO:0071874 | cellular response to norepinephrine stimulus | 8.333538e-4 |
GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 8.587377e-4 |
GO:0045163 | clustering of voltage-gated potassium channels | 8.587377e-4 |
GO:0032703 | negative regulation of interleukin-2 production | 8.588094e-4 |
GO:0051272 | positive regulation of cellular component movement | 8.697657e-4 |
GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 8.711296e-4 |
GO:0030217 | T cell differentiation | 8.769396e-4 |
GO:0009886 | post-embryonic morphogenesis | 8.791782e-4 |
GO:0048278 | vesicle docking | 9.059850e-4 |
GO:0007525 | somatic muscle development | 9.183999e-4 |
GO:0033280 | response to vitamin D | 9.424754e-4 |
GO:0006290 | pyrimidine dimer repair | 9.483731e-4 |
GO:0060088 | auditory receptor cell stereocilium organization | 9.485026e-4 |
GO:0055013 | cardiac muscle cell development | 9.534807e-4 |
GO:0030509 | BMP signaling pathway | 9.941676e-4 |
GO:0007624 | ultradian rhythm | 1.011516e-3 |
GO:0070474 | positive regulation of uterine smooth muscle contraction | 1.038541e-3 |
GO:0071218 | cellular response to misfolded protein | 1.068831e-3 |
GO:0070684 | seminal clot liquefaction | 1.092869e-3 |
GO:2000009 | negative regulation of protein localization at cell surface | 1.092869e-3 |
GO:0060262 | negative regulation of N-terminal protein palmitoylation | 1.092869e-3 |
GO:0006882 | cellular zinc ion homeostasis | 1.111296e-3 |
GO:0032287 | peripheral nervous system myelin maintenance | 1.160484e-3 |
GO:0006979 | response to oxidative stress | 1.169304e-3 |
GO:0014741 | negative regulation of muscle hypertrophy | 1.171432e-3 |
GO:0032006 | regulation of TOR signaling cascade | 1.184841e-3 |
GO:0071345 | cellular response to cytokine stimulus | 1.190334e-3 |
GO:0021960 | anterior commissure morphogenesis | 1.199342e-3 |
GO:0002262 | myeloid cell homeostasis | 1.219063e-3 |
GO:0035137 | hindlimb morphogenesis | 1.249573e-3 |
GO:0060259 | regulation of feeding behavior | 1.251784e-3 |
GO:0090362 | positive regulation of platelet-derived growth factor production | 1.254109e-3 |
GO:0090271 | positive regulation of fibroblast growth factor production | 1.254109e-3 |
GO:0090336 | positive regulation of brown fat cell differentiation | 1.254109e-3 |
GO:0045591 | positive regulation of regulatory T cell differentiation | 1.264752e-3 |
GO:0015850 | organic alcohol transport | 1.273740e-3 |
GO:0060428 | lung epithelium development | 1.294044e-3 |
GO:0012502 | induction of programmed cell death | 1.319532e-3 |
GO:0001706 | endoderm formation | 1.344530e-3 |
GO:0051453 | regulation of intracellular pH | 1.351591e-3 |
GO:0007512 | adult heart development | 1.364417e-3 |
GO:0033151 | V(D)J recombination | 1.410958e-3 |
GO:0006917 | induction of apoptosis | 1.428307e-3 |
GO:0033152 | immunoglobulin V(D)J recombination | 1.430713e-3 |
GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 1.474587e-3 |
GO:0002064 | epithelial cell development | 1.480430e-3 |
GO:0051176 | positive regulation of sulfur metabolic process | 1.482289e-3 |
GO:0035441 | cell migration involved in vasculogenesis | 1.482289e-3 |
GO:0007271 | synaptic transmission, cholinergic | 1.486058e-3 |
GO:0007565 | female pregnancy | 1.499389e-3 |
GO:0051583 | dopamine uptake | 1.515353e-3 |
GO:0032332 | positive regulation of chondrocyte differentiation | 1.538266e-3 |
GO:0050434 | positive regulation of viral transcription | 1.581634e-3 |
GO:0002065 | columnar/cuboidal epithelial cell differentiation | 1.625513e-3 |
GO:0045321 | leukocyte activation | 1.652527e-3 |
GO:0031936 | negative regulation of chromatin silencing | 1.659213e-3 |
GO:0015793 | glycerol transport | 1.714293e-3 |
GO:0045766 | positive regulation of angiogenesis | 1.784857e-3 |
GO:0060039 | pericardium development | 1.799696e-3 |
GO:0051013 | microtubule severing | 1.818444e-3 |
GO:0070163 | regulation of adiponectin secretion | 1.829237e-3 |
GO:0000059 | protein import into nucleus, docking | 1.829237e-3 |
GO:0032769 | negative regulation of monooxygenase activity | 1.841217e-3 |
GO:0007021 | tubulin complex assembly | 1.860236e-3 |
GO:0002315 | marginal zone B cell differentiation | 1.860236e-3 |
GO:0006007 | glucose catabolic process | 1.870124e-3 |
GO:0032321 | positive regulation of Rho GTPase activity | 1.879988e-3 |
GO:0006885 | regulation of pH | 1.926067e-3 |
GO:0032231 | regulation of actin filament bundle assembly | 1.999485e-3 |
GO:0035024 | negative regulation of Rho protein signal transduction | 2.012204e-3 |
GO:0050892 | intestinal absorption | 2.018518e-3 |
GO:0002335 | mature B cell differentiation | 2.061620e-3 |
GO:0003013 | circulatory system process | 2.074518e-3 |
GO:0070542 | response to fatty acid | 2.084248e-3 |
GO:0046007 | negative regulation of activated T cell proliferation | 2.106890e-3 |
GO:0044340 | canonical Wnt receptor signaling pathway involved in regulation of cell proliferation | 2.106890e-3 |
GO:0002093 | auditory receptor cell morphogenesis | 2.112648e-3 |
GO:0019320 | hexose catabolic process | 2.138496e-3 |
GO:0007042 | lysosomal lumen acidification | 2.156976e-3 |
GO:2000725 | regulation of cardiac muscle cell differentiation | 2.163593e-3 |
GO:0002329 | pre-B cell differentiation | 2.177973e-3 |
GO:0007224 | smoothened signaling pathway | 2.197264e-3 |
GO:0050689 | negative regulation of defense response to virus by host | 2.199920e-3 |
GO:0018158 | protein oxidation | 2.199920e-3 |
GO:0072573 | tolerance induction to lipopolysaccharide | 2.233887e-3 |
GO:2000349 | negative regulation of CD40 signaling pathway | 2.233887e-3 |
GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 2.233887e-3 |
GO:0070429 | negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 2.233887e-3 |
GO:0034148 | negative regulation of toll-like receptor 5 signaling pathway | 2.233887e-3 |
GO:0002632 | negative regulation of granuloma formation | 2.233887e-3 |
GO:0034421 | post-translational protein acetylation | 2.259900e-3 |
GO:0002851 | positive regulation of peripheral T cell tolerance induction | 2.259900e-3 |
GO:0032819 | positive regulation of natural killer cell proliferation | 2.283514e-3 |
GO:0021943 | formation of radial glial scaffolds | 2.283514e-3 |
GO:0048146 | positive regulation of fibroblast proliferation | 2.291723e-3 |
GO:0030223 | neutrophil differentiation | 2.310624e-3 |
GO:0034976 | response to endoplasmic reticulum stress | 2.368124e-3 |
GO:0008217 | regulation of blood pressure | 2.397061e-3 |
GO:0043666 | regulation of phosphoprotein phosphatase activity | 2.404490e-3 |
GO:0022408 | negative regulation of cell-cell adhesion | 2.408525e-3 |
GO:0031954 | positive regulation of protein autophosphorylation | 2.422084e-3 |
GO:0002507 | tolerance induction | 2.430637e-3 |
GO:0031952 | regulation of protein autophosphorylation | 2.469291e-3 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB cascade | 2.488741e-3 |
GO:0007566 | embryo implantation | 2.501079e-3 |
GO:0006941 | striated muscle contraction | 2.501672e-3 |
GO:0006750 | glutathione biosynthetic process | 2.540958e-3 |
GO:0055069 | zinc ion homeostasis | 2.546929e-3 |
GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 2.557630e-3 |
GO:0070509 | calcium ion import | 2.586301e-3 |
GO:0033240 | positive regulation of cellular amine metabolic process | 2.586301e-3 |
GO:0007276 | gamete generation | 2.599393e-3 |
GO:0043010 | camera-type eye development | 2.608926e-3 |
GO:0048293 | regulation of isotype switching to IgE isotypes | 2.661170e-3 |
GO:0042668 | auditory receptor cell fate determination | 2.673550e-3 |
GO:0022011 | myelination in peripheral nervous system | 2.710119e-3 |
GO:0021781 | glial cell fate commitment | 2.717042e-3 |
GO:0009064 | glutamine family amino acid metabolic process | 2.746595e-3 |
GO:0045601 | regulation of endothelial cell differentiation | 2.752975e-3 |
GO:0010821 | regulation of mitochondrion organization | 2.761316e-3 |
GO:0060041 | retina development in camera-type eye | 2.793207e-3 |
GO:0048294 | negative regulation of isotype switching to IgE isotypes | 2.866137e-3 |
GO:0060487 | lung epithelial cell differentiation | 2.871302e-3 |
GO:0071895 | odontoblast differentiation | 2.872509e-3 |
GO:0070432 | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 2.872509e-3 |
GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 2.872509e-3 |
GO:0033127 | regulation of histone phosphorylation | 2.876915e-3 |
GO:0031117 | positive regulation of microtubule depolymerization | 2.876915e-3 |
GO:0045793 | positive regulation of cell size | 2.880220e-3 |
GO:0006749 | glutathione metabolic process | 2.881232e-3 |
GO:0070670 | response to interleukin-4 | 2.923140e-3 |
GO:0045988 | negative regulation of striated muscle contraction | 2.948961e-3 |
GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide | 2.989094e-3 |
GO:0006256 | UDP catabolic process | 3.006696e-3 |
GO:0009405 | pathogenesis | 3.006696e-3 |
GO:0046164 | alcohol catabolic process | 3.015893e-3 |
GO:0008016 | regulation of heart contraction | 3.042140e-3 |
GO:0060019 | radial glial cell differentiation | 3.075014e-3 |
GO:0006177 | GMP biosynthetic process | 3.092377e-3 |
GO:0010927 | cellular component assembly involved in morphogenesis | 3.137963e-3 |
GO:0060713 | labyrinthine layer morphogenesis | 3.166164e-3 |
GO:0048841 | regulation of axon extension involved in axon guidance | 3.200897e-3 |
GO:0044241 | lipid digestion | 3.281656e-3 |
GO:0032792 | negative regulation of CREB transcription factor activity | 3.294050e-3 |
GO:0014045 | establishment of endothelial blood-brain barrier | 3.294050e-3 |
GO:0006538 | glutamate catabolic process | 3.315571e-3 |
GO:0032268 | regulation of cellular protein metabolic process | 3.325719e-3 |
GO:0046365 | monosaccharide catabolic process | 3.392078e-3 |
GO:0042113 | B cell activation | 3.413449e-3 |
GO:0002432 | granuloma formation | 3.421914e-3 |
GO:0048715 | negative regulation of oligodendrocyte differentiation | 3.492265e-3 |
GO:0061153 | trachea gland development | 3.563070e-3 |
GO:0048069 | eye pigmentation | 3.563070e-3 |
GO:0035116 | embryonic hindlimb morphogenesis | 3.568410e-3 |
GO:0014075 | response to amine stimulus | 3.582312e-3 |
GO:0001704 | formation of primary germ layer | 3.628643e-3 |
GO:0061188 | negative regulation of chromatin silencing at rDNA | 3.718057e-3 |
GO:0061050 | regulation of cell growth involved in cardiac muscle cell development | 3.718057e-3 |
GO:0002725 | negative regulation of T cell cytokine production | 3.802938e-3 |
GO:0009088 | threonine biosynthetic process | 3.868996e-3 |
GO:0070060 | 'de novo' actin filament nucleation | 3.868996e-3 |
GO:0003273 | cell migration involved in endocardial cushion formation | 3.868996e-3 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 3.949808e-3 |
GO:2000147 | positive regulation of cell motility | 4.038348e-3 |
GO:0046112 | nucleobase biosynthetic process | 4.051832e-3 |
GO:0050909 | sensory perception of taste | 4.053463e-3 |
GO:0097150 | neuronal stem cell maintenance | 4.113920e-3 |
GO:0003382 | epithelial cell morphogenesis | 4.147809e-3 |
GO:0001932 | regulation of protein phosphorylation | 4.205384e-3 |
GO:0072523 | purine-containing compound catabolic process | 4.241522e-3 |
GO:0010963 | regulation of L-arginine import | 4.310793e-3 |
GO:0015722 | canalicular bile acid transport | 4.310793e-3 |
GO:0051125 | regulation of actin nucleation | 4.397773e-3 |
GO:0035265 | organ growth | 4.407277e-3 |
GO:0055067 | monovalent inorganic cation homeostasis | 4.425257e-3 |
GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 4.434603e-3 |
GO:0031935 | regulation of chromatin silencing | 4.452285e-3 |
GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis | 4.461448e-3 |
GO:2000791 | negative regulation of mesenchymal cell proliferation involved in lung development | 4.461448e-3 |
GO:2000980 | regulation of inner ear receptor cell differentiation | 4.461448e-3 |
GO:0021740 | principal sensory nucleus of trigeminal nerve development | 4.461448e-3 |
GO:0061141 | lung ciliated cell differentiation | 4.461448e-3 |
GO:2000347 | positive regulation of hepatocyte proliferation | 4.461448e-3 |
GO:0060415 | muscle tissue morphogenesis | 4.461942e-3 |
GO:0006195 | purine nucleotide catabolic process | 4.493944e-3 |
GO:0051788 | response to misfolded protein | 4.546180e-3 |
GO:0040017 | positive regulation of locomotion | 4.560328e-3 |
GO:0071624 | positive regulation of granulocyte chemotaxis | 4.669598e-3 |
GO:0071105 | response to interleukin-11 | 4.669598e-3 |
GO:0031629 | synaptic vesicle fusion to presynaptic membrane | 4.669598e-3 |
GO:0030818 | negative regulation of cAMP biosynthetic process | 4.752084e-3 |
GO:0006566 | threonine metabolic process | 4.769631e-3 |
GO:0006014 | D-ribose metabolic process | 4.865082e-3 |
GO:0051146 | striated muscle cell differentiation | 4.869428e-3 |
GO:0071870 | cellular response to catecholamine stimulus | 4.893768e-3 |
GO:0002832 | negative regulation of response to biotic stimulus | 4.911401e-3 |
GO:0072273 | metanephric nephron morphogenesis | 4.924698e-3 |
GO:0003338 | metanephros morphogenesis | 4.973896e-3 |
GO:0010822 | positive regulation of mitochondrion organization | 4.977778e-3 |
GO:0010627 | regulation of intracellular protein kinase cascade | 5.019869e-3 |
GO:0006906 | vesicle fusion | 5.034576e-3 |
GO:2000345 | regulation of hepatocyte proliferation | 5.055735e-3 |
GO:0060117 | auditory receptor cell development | 5.074372e-3 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 5.107106e-3 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 5.107106e-3 |
GO:0006360 | transcription from RNA polymerase I promoter | 5.204846e-3 |
GO:0018345 | protein palmitoylation | 5.215465e-3 |
GO:0045077 | negative regulation of interferon-gamma biosynthetic process | 5.226663e-3 |
GO:0019220 | regulation of phosphate metabolic process | 5.318079e-3 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5.323817e-3 |
GO:0003214 | cardiac left ventricle morphogenesis | 5.355771e-3 |
GO:0006096 | glycolysis | 5.399626e-3 |
GO:0043171 | peptide catabolic process | 5.444482e-3 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 5.450938e-3 |
GO:0032776 | DNA methylation on cytosine | 5.482557e-3 |
GO:0015791 | polyol transport | 5.561484e-3 |
GO:0006474 | N-terminal protein amino acid acetylation | 5.561484e-3 |
GO:0009750 | response to fructose stimulus | 5.684028e-3 |
GO:0042439 | ethanolamine-containing compound metabolic process | 5.792694e-3 |
GO:0048241 | epinephrine transport | 5.838438e-3 |
GO:0048548 | regulation of pinocytosis | 5.884909e-3 |
GO:0042415 | norepinephrine metabolic process | 5.948308e-3 |
GO:0051937 | catecholamine transport | 5.948308e-3 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 6.011062e-3 |
GO:0034971 | histone H3-R17 methylation | 6.011062e-3 |
GO:0009691 | cytokinin biosynthetic process | 6.011062e-3 |
GO:0007010 | cytoskeleton organization | 6.016231e-3 |
GO:0051890 | regulation of cardioblast differentiation | 6.029214e-3 |
GO:0032817 | regulation of natural killer cell proliferation | 6.054319e-3 |
GO:0050953 | sensory perception of light stimulus | 6.181362e-3 |
GO:0035136 | forelimb morphogenesis | 6.195918e-3 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 6.343069e-3 |
GO:0010043 | response to zinc ion | 6.366923e-3 |
GO:0043951 | negative regulation of cAMP-mediated signaling | 6.377681e-3 |
GO:0007369 | gastrulation | 6.441373e-3 |
GO:0000082 | G1/S transition of mitotic cell cycle | 6.446238e-3 |
GO:0006914 | autophagy | 6.446887e-3 |
GO:0090023 | positive regulation of neutrophil chemotaxis | 6.478279e-3 |
GO:0031110 | regulation of microtubule polymerization or depolymerization | 6.515949e-3 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 6.579640e-3 |
GO:0017156 | calcium ion-dependent exocytosis | 6.581405e-3 |
GO:0033077 | T cell differentiation in thymus | 6.617027e-3 |
GO:0001886 | endothelial cell morphogenesis | 6.634442e-3 |
GO:0010424 | DNA methylation on cytosine within a CG sequence | 6.654294e-3 |
GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway | 6.780954e-3 |
GO:0071109 | superior temporal gyrus development | 6.786749e-3 |
GO:0048034 | heme O biosynthetic process | 6.786749e-3 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 6.786749e-3 |
GO:0070972 | protein localization in endoplasmic reticulum | 6.794671e-3 |
GO:0046425 | regulation of JAK-STAT cascade | 6.799744e-3 |
GO:0060929 | atrioventricular node cell fate commitment | 6.815767e-3 |
GO:0090042 | tubulin deacetylation | 6.815767e-3 |
GO:0070846 | Hsp90 deacetylation | 6.815767e-3 |
GO:0060928 | atrioventricular node cell development | 6.815767e-3 |
GO:0003168 | cardiac Purkinje fiber cell differentiation | 6.815767e-3 |
GO:0003342 | proepicardium development | 6.815767e-3 |
GO:0042073 | intraflagellar transport | 6.815767e-3 |
GO:0007015 | actin filament organization | 6.833251e-3 |
GO:0042424 | catecholamine catabolic process | 6.843248e-3 |
GO:0045603 | positive regulation of endothelial cell differentiation | 6.876046e-3 |
GO:0045682 | regulation of epidermis development | 6.907055e-3 |
GO:0042487 | regulation of odontogenesis of dentine-containing tooth | 6.932367e-3 |
GO:0035247 | peptidyl-arginine omega-N-methylation | 6.941140e-3 |
GO:0042692 | muscle cell differentiation | 6.952920e-3 |
GO:0008015 | blood circulation | 7.040551e-3 |
GO:0046631 | alpha-beta T cell activation | 7.172168e-3 |
GO:0060327 | cytoplasmic actin-based contraction involved in cell motility | 7.206880e-3 |
GO:2000392 | regulation of lamellipodium morphogenesis | 7.206880e-3 |
GO:0070141 | response to UV-A | 7.220799e-3 |
GO:0043096 | purine base salvage | 7.252641e-3 |
GO:0060122 | inner ear receptor stereocilium organization | 7.564835e-3 |
GO:0007601 | visual perception | 7.590827e-3 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 7.685684e-3 |
GO:0071712 | ER-associated misfolded protein catabolic process | 7.687787e-3 |
GO:0042048 | olfactory behavior | 7.687787e-3 |
GO:0007341 | penetration of zona pellucida | 7.806270e-3 |
GO:0071353 | cellular response to interleukin-4 | 7.811435e-3 |
GO:0051891 | positive regulation of cardioblast differentiation | 7.817692e-3 |
GO:0090116 | C-5 methylation of cytosine | 7.881276e-3 |
GO:0051591 | response to cAMP | 7.928983e-3 |
GO:0042178 | xenobiotic catabolic process | 8.034476e-3 |
GO:0032007 | negative regulation of TOR signaling cascade | 8.034476e-3 |
GO:0007217 | tachykinin receptor signaling pathway | 8.034476e-3 |
GO:0032714 | negative regulation of interleukin-5 production | 8.070865e-3 |
GO:0060509 | Type I pneumocyte differentiation | 8.240309e-3 |
GO:0042347 | negative regulation of NF-kappaB import into nucleus | 8.240309e-3 |
GO:0097084 | vascular smooth muscle cell development | 8.262977e-3 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 8.282999e-3 |
GO:0043380 | regulation of memory T cell differentiation | 8.553224e-3 |
GO:0022898 | regulation of transmembrane transporter activity | 8.642245e-3 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 8.667909e-3 |
GO:0032227 | negative regulation of synaptic transmission, dopaminergic | 8.667909e-3 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 8.674720e-3 |
GO:0020027 | hemoglobin metabolic process | 8.738474e-3 |
GO:0007606 | sensory perception of chemical stimulus | 8.739794e-3 |
GO:0002639 | positive regulation of immunoglobulin production | 8.863976e-3 |
GO:0061088 | regulation of sequestering of zinc ion | 8.921459e-3 |
GO:0060060 | post-embryonic retina morphogenesis in camera-type eye | 8.921459e-3 |
GO:0032204 | regulation of telomere maintenance | 8.934733e-3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 9.039658e-3 |
GO:0002687 | positive regulation of leukocyte migration | 9.049045e-3 |
GO:0072215 | regulation of metanephros development | 9.064076e-3 |
GO:0071034 | CUT catabolic process | 9.169459e-3 |
GO:0042045 | epithelial fluid transport | 9.169459e-3 |
GO:0048842 | positive regulation of axon extension involved in axon guidance | 9.169459e-3 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 9.181398e-3 |
GO:0045980 | negative regulation of nucleotide metabolic process | 9.185747e-3 |
GO:0048644 | muscle organ morphogenesis | 9.268694e-3 |
GO:0072282 | metanephric nephron tubule morphogenesis | 9.269932e-3 |
GO:0030335 | positive regulation of cell migration | 9.478881e-3 |
GO:0015872 | dopamine transport | 9.557701e-3 |
GO:0008631 | induction of apoptosis by oxidative stress | 9.612228e-3 |
GO:0060575 | intestinal epithelial cell differentiation | 9.624163e-3 |
GO:0048388 | endosomal lumen acidification | 9.795025e-3 |
GO:0045815 | positive regulation of gene expression, epigenetic | 9.831054e-3 |
GO:0006281 | DNA repair | 9.844064e-3 |
GO:0051593 | response to folic acid | 9.877688e-3 |
GO:0072239 | metanephric glomerulus vasculature development | 9.995332e-3 |
GO:0008366 | axon ensheathment | 1.012782e-2 |
GO:0051493 | regulation of cytoskeleton organization | 1.024462e-2 |